Skip to main content

travoprost

Generic: TRAVOPROST·Brand: IDOSE TR, IZBA, TRAVATAN, TRAVATAN Z, TRAVOPROST

travoprost: sourced relationships with 1 company · 1 FDA decision.

travoprost evidence translation

What we can confirm

1 FDA record

What it means

Source-backed records connect travoprost to NVS; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could travoprost → NVS affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (2)
CompanyDated record stage
Novartis AG (NVS)
Reported 2014-05-15 · Current development: unknownSource
Approved
Novartis AG (NVS)
Reported 2014-05-15 · Current development: unknownSource
Approved
FDA Decisions1 records
Approval(NVS)FDA ↗
NDA204822Type 5 - New Formulation or New ManufacturerStandardOphthalmicSolution/Drops

Frequently asked questions

Which companies have sourced relationships with travoprost?

travoprost has dated SEC/FDA relationship records for Novartis AG.

What is travoprost's latest FDA decision?

The most recent tracked FDA decision for travoprost is Approval, dated May 15, 2014.